Home › Brain Stem Infarctions › NCT06511934
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
Intuitive, Complete Neural Control of Tablet Computers for Communication
Who can join
Ages 18 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy, amyotrophic lateral sclerosis or other motor neuron disorders * Complete or incomplete tetraplegia (quadriplegia) * Must live within a three-hour drive of the Study site * Prior enrollment in BrainGate2 clinical trial (NCT00912041) Exclusion Criteria: * Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses * Chronic oral or intravenous steroids or immunosuppressive therapy * Other serious disease or disorder that could seriously affect ability to participate in the study (There are additional exclusion criteria)
About the study
People with brainstem stroke, advanced amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), or other disorders can become unable to move or speak despite being awake and alert. In this project, the investigators seek to further translate knowledge about interpreting brain signals related to movement, and to further develop an intracortical brain-computer interface (iBCI) that could restore rapid and intuitive use of communication apps on tablet computers by people with paralysis.
What is being tested
- BrainGate Neural Interface System (device)
Sponsor: Leigh R. Hochberg, MD, PhD. · Participants: 6 · Started: Jul 22, 2024
Contact the study team
- Leigh R Hochberg, MD, Ph.D · Phone: 617-724-9247
Official record on ClinicalTrials.gov — NCT06511934
Locations in the U.S.
| Massachusetts | Masssachusetts General Hospital, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.